Eli Lilly and Company today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton tyrosine kinase (BTK) ...

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...

Blood plasma is a necessary resource to produce life-saving medicine. Because people are the only source, donors are often ...

CSL will outlay $1.5bn over the next five years in the US to grow its footprint of plasma therapy production, the latest pharma company to pour money into the country amid tariff threats.

(Reuters) -Australian biotech firm CSL said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its footprint in the North American country ...

The world’s supply of many life-saving medications depends on people in the United States deciding to sell their blood plasma ...

A newly-constructed building intended to house a plasma center later this year is now on the market. The facility for ImmunoTek Plasma Center, located at 5510 N. Belt West in Belleville, is currently ...

Nuclear fusion, which operates on the same principle that powers the sun, is expected to become a sustainable energy source for the future. To achieve fusion power generation, it is essential to ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the successful completion of the U.S. rollout ...

The recent passage of a countywide sales tax measure is expected to soften federal funding cuts to Silicon Valley’s largest ...

LA Plastic Surgery: The Skin Plasma Center at 5301 4th Avenue Circle East, Bradenton, FL on Nov. 11, 2025. Tiffany Tompkins [email protected] The doctor in charge of making sure a Bradenton ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the ...